staurosporine aglycone has been researched along with Facial Pain in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
Excerpt | Relevance | Reference |
---|---|---|
"CFA injection induced heat hyperalgesia of the ipsilateral whisker pad skin." | 1.37 | Nerve growth factor contribution via transient receptor potential vanilloid 1 to ectopic orofacial pain. ( Asano, M; Hitomi, S; Honda, K; Iwata, K; Katagiri, A; Omagari, D; Shinoda, M, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shinoda, M | 1 |
Asano, M | 1 |
Omagari, D | 1 |
Honda, K | 1 |
Hitomi, S | 1 |
Katagiri, A | 1 |
Iwata, K | 1 |
1 other study available for staurosporine aglycone and Facial Pain
Article | Year |
---|---|
Nerve growth factor contribution via transient receptor potential vanilloid 1 to ectopic orofacial pain.
Topics: Analysis of Variance; Animals; Antibodies, Neutralizing; Behavior, Animal; Blotting, Western; Carbaz | 2011 |